BCiting health risks, Barbados orders Prexige off the market

Broad Street Journal Online "Barbados’ Ministry of Health announced yesterday that it has suspended the marketing and sale of the prescription drug Prexige, and advised patients to immediately discontinue using it. This suspension follows similar action taken by Australia, Canada, Austria, the United Kingdom and Germany and relates to concerns expressed about liver related adverse effects, the GIS reported. The announcement came two months after Canada’s health authorities warned consumers on October 4 about potential liver-related adverse effects, including hepatitis, linked to the anti-inflammatory medicine."